Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Alteris Therapeutics Inc.

This article was originally published in Start Up

Executive Summary

While a postdoc at Johns Hopkins University in the mid-1980s, Albert Wong, MD, made a fortuitous discovery that would form the basis of a start-up, Alteris Therapeutics Inc. (formerly Spliceomix Inc.), he eventually co-founded almost fifteen years later. His research-studying genes amplified in brain tumors-led him to investigate one of the better-known targets at the time: the EGF receptor (EGFR).


Related Companies

Related Deals




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts